Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Tumori|August 19, 2008
Factors predictive of response to hormone therapy in breast cancerFrancesca Rastelli, Sergio Crispino
Ecancermedicalscience|February 20, 2018
Does the oncology community have a rejection bias when it comes to repurposed drugs?Bishal Gyawali, Pan Pantziarka, Sergio Crispino, et al.
Palliative & Supportive Care|February 19, 2010
Art therapy with cancer patients during chemotherapy sessions: an analysis of the patients' perception of helpfulnessSilvia Forzoni, Michela Perez, Angelo Martignetti, et al.
Ecancermedicalscience|July 31, 2020
Repurposing of drugs for triple negative breast cancer: an overviewAndrea Spini, Sandra Donnini, Pan Pantziarka, et al.
Ecancermedicalscience|July 24, 2018
Propranolol and breast cancer-a work in progressPan Pantziarka, Brad A Bryan, Sergio Crispino, et al.
Ecancermedicalscience|May 11, 2018
Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agentsPan Pantziarka, Vidula Sukhatme, Sergio Crispino, et al.
Tumori|July 31, 2014
"Green Oncology": the Italian medical oncologists' challenge to reduce the ecological impact of their clinical activitySergio Bretti, Gianfranco Porcile, Roberto Romizi, et al.
Redox Report : Communications in Free Radical Research|February 10, 2021
Redox imbalance induced by docetaxel in the neuroblastoma SH-SY5Y cells: a study of docetaxel-induced neuronal damageLucia Micheli, Giulia Collodel, Elena Moretti, et al.
Tumori|March 11, 2011
Triple-negative breast cancer: current state of the artFrancesca Rastelli, Sandra Biancanelli, Amalia Falzetta, et al.
Tumori|October 13, 2011
Use of metronomic chemotherapy in oncology: results from a national Italian surveyElena Collovà, Federica Sebastiani, Elisabetta De Matteis, et al.
Pageof 2